Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-04-22

FDA Approved: AMLODIPINE AND VALSARTAN — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved the original application for a generic fixed-dose combination of amlodipine and valsartan by Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMLODIPINE AND VALSARTAN (amlodipine and valsartan)

Snippet

ORIG AP for AMLODIPINE AND VALSARTAN (AMLODIPINE AND VALSARTAN)